ITGR Integer Holdings Corporation

Integer Announces Conference Call to Discuss Second Quarter 2025 Results

Integer Announces Conference Call to Discuss Second Quarter 2025 Results

PLANO, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the second quarter ended June 27, 2025, on Thursday, July 24, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release announcing financial results for the second quarter on July 24 prior to the conference call.

Conference call details:

  • Date: Thursday, July 24, 2025
  • Time: 8 a.m. CT / 9 a.m. ET
  • Domestic dial-in number: (800) 715-9871
  • International dial-in number: (646) 307-1963
  • Conference ID: 3120125
  • Webcast Registration:

An audio replay will be available for seven days and can be accessed by dialing (800) 770-2030 or (609) 800-9909 and using Conference ID 3120125. The conference call will also be available live or via archived replay on the Investor Relations section of the Integer website at: .

From time to time, Integer posts information that may be of interest to investors on its website. To automatically receive Integer financial news by email, please visit and subscribe to email alerts.

Learn more about Integer at .

About Integer®

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at .

Investor Relations:

Kristen Stewart

551.337.3973
Media Relations:

Kelly Butler



469.731.6617



EN
26/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integer Holdings Corporation

 PRESS RELEASE

Integer to Showcase Innovations in Neuromodulation, Miniaturized Activ...

Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting ~ Attendees Invited to Visit Integer at Booth #115 ~ PLANO, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) --  Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Las Vegas from Jan. 22 – 25, 2026. At booth #115, Integer will spotlight...

 PRESS RELEASE

Integer to Participate at Upcoming Investor Conferences

Integer to Participate at Upcoming Investor Conferences PLANO, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, announced today that members of its executive leadership team will participate at the following investor conferences in December: Piper Sandler 37th Annual Healthcare Conference at 8:00 a.m. ET on Tuesday, Dec. 2Citi’s 2025 Global Healthcare Conference at 9:45 a.m. ET on Wednesday, Dec. 3 A live webcast and replay for each event will be accessible under “News & Even...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 15, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Integer Holdings Corp: 2 directors

Two Directors at Integer Holdings Corp sold/bought 2,534 shares at between 70.000USD and 70.150USD. The significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch